{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:08:45Z","timestamp":1792886925490,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s40266-020-00796-5","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T12:02:35Z","timestamp":1599480155000},"page":"725-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2736-2242","authenticated-orcid":false,"given":"Giulia","family":"Rivasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rafanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Mossello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Brignole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"796_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","volume":"161","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161:46\u20138.","journal-title":"Auton Neurosci."},{"issue":"21","key":"796_CR2","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/eurheartj\/ehy071","volume":"39","author":"M Brignole","year":"2018","unstructured":"Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):e43\u201380.","journal-title":"Eur Heart J."},{"key":"796_CR3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jamda.2019.01.149","volume":"20","author":"A Ceccofiglio","year":"2019","unstructured":"Ceccofiglio A, Mussi C, Rafanelli M, et al. Increasing prevalence of orthostatic hypotension as a cause of syncope with advancing age and multimorbidity. J Am Med Dir Assoc. 2019;20:586\u20138.","journal-title":"J Am Med Dir Assoc."},{"key":"796_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","volume":"31","author":"A Fedorowski","year":"2010","unstructured":"Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31:85\u201391.","journal-title":"Eur Heart J"},{"key":"796_CR5","doi-asserted-by":"crossref","first-page":"e002143","DOI":"10.1371\/journal.pmed.1002143","volume":"13","author":"FJ Wolters","year":"2016","unstructured":"Wolters FJ, Mattace-Raso FU, Koudstaal PJ, Heart Brain Connection Collaborative Research Group, et al. Orthostatic hypotension and the long-term risk of dementia: a population-based study. PLoS Med. 2016;13:e002143.","journal-title":"PLoS Med."},{"key":"796_CR6","volume-title":"Brain and heart dynamics","author":"E Mossello","year":"2020","unstructured":"Mossello E, Marchionni N. Vascular risk factors and cognitive function. the effect of aging process. In: Govoni S, et al., editors. Brain and heart dynamics. Switzerland: Springer Nature; 2020."},{"issue":"5","key":"796_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/j.1552-4604.1994.tb04977.x","volume":"34","author":"JJ Smith","year":"1994","unstructured":"Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. J Clin Pharmacol. 1994;34(5):375\u201386.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"796_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50(1):47\u201353.","journal-title":"Hypertension."},{"key":"796_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00044011-199714010-00008","volume":"14","author":"JL Montastruc","year":"1997","unstructured":"Montastruc JL, Laborie I, Bagheri H, Senard JM. Drug-induced orthostatic hypotension. A five-year experience in a regional pharmacovigilance centre in France. Clin Drug Investig. 1997;14:61.","journal-title":"Clin Drug Investig."},{"key":"796_CR10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","volume":"14","author":"ES ElDesoky","year":"2007","unstructured":"ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007;14:488\u201398.","journal-title":"Am J Ther."},{"issue":"2","key":"796_CR11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ageing\/afv199","volume":"45","author":"JE Moonen","year":"2016","unstructured":"Moonen JE, Foster-Dingley JC, de Ruijter W, van der Grond J, de Craen AJ, van der Mast RC. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden. Age Ageing. 2016;45(2):249\u201355.","journal-title":"Age Ageing."},{"issue":"2","key":"796_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00002018-199717020-00003","volume":"17","author":"I Verhaeverbeke","year":"1997","unstructured":"Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Saf. 1997;17(2):105\u201318.","journal-title":"Drug Saf."},{"issue":"Suppl 1","key":"796_CR13","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/pme.12915","volume":"16","author":"A Chen","year":"2015","unstructured":"Chen A, Ashburn MA. Cardiac effects of opioid therapy. Pain Med. 2015;16(Suppl 1):S27\u201331.","journal-title":"Pain Med."},{"issue":"9","key":"796_CR14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/europace\/euq168","volume":"12","author":"A Fedorowski","year":"2010","unstructured":"Fedorowski A, Burri P, Juul-M\u00f6ller S, Melander O. A dedicated investigation unit improves management of syncopal attacks (Syncope Study of Unselected Population in Malmo\u2013SYSTEMA I). Europace. 2010;12(9):1322\u20138.","journal-title":"Europace."},{"issue":"1","key":"796_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ageing\/afp192","volume":"39","author":"S Kamaruzzaman","year":"2010","unstructured":"Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women\u2019s Heart and Health Study. Age Ageing. 2010;39(1):51\u20136.","journal-title":"Age Ageing."},{"issue":"7","key":"796_CR16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/gerona\/glp028","volume":"64","author":"C Mussi","year":"2009","unstructured":"Mussi C, Ungar A, Salvioli G, Menozzi C, Bartoletti A, Giada F, Evaluation of Guidelines in Syncope Study 2 Group, et al. Orthostatic hypotension as cause of syncope in patients older than 65 years admitted to emergency departments for transient loss of consciousness. J Gerontol A Biol Sci Med Sci. 2009;64(7):801\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"796_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2710.2005.00629.x","volume":"30","author":"IO Poon","year":"2005","unstructured":"Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005;30:173\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"796_CR18","doi-asserted-by":"crossref","first-page":"e0146156","DOI":"10.1371\/journal.pone.0146156","volume":"11","author":"M Canney","year":"2016","unstructured":"Canney M, O\u2019Connell MD, Murphy CM, O\u2019Leary N, Little MA, O\u2019Seaghdha CM, Kenny RA. Single agent antihypertensive therapy and orthostatic blood pressure behaviour in older adults using beat-to-beat measurements: the irish longitudinal study on ageing. PLoS One. 2016;11(1):e0146156.","journal-title":"PLoS One."},{"key":"796_CR19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinte.1995.00430090067008","volume":"155","author":"I Raiha","year":"1995","unstructured":"Raiha I, Luutonen S, Piha J, Seppanen A, Toikka T, et al. Prevalence, predisposing factors, and prognostic importance of postural hypotension. Arch Intern Med. 1995;155:930\u20135.","journal-title":"Arch Intern Med"},{"key":"796_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc08-1389","volume":"32","author":"JS Wu","year":"2009","unstructured":"Wu JS, Yang YC, Lu FH, Wu CH, Wang RH, et al. Population-based study on the prevalence and risk factors of orthostatic hypotension in subjects with pre-diabetes and diabetes. Diabetes Care. 2009;32:69\u201374.","journal-title":"Diabetes Care"},{"key":"796_CR21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0895-7061(99)00257-5","volume":"13","author":"KM Rose","year":"2000","unstructured":"Rose KM, Tyroler HA, Nardo CJ, Arnett DK, Light KC, et al. Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study. Am J Hypertens. 2000;13:571\u20138.","journal-title":"Am J Hypertens"},{"key":"796_CR22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/CIRCULATIONAHA.105.598722","volume":"114","author":"KM Rose","year":"2006","unstructured":"Rose KM, Eigenbrodt ML, Biga RL, Couper DJ, Light KC, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006;114:630\u20136.","journal-title":"Circulation"},{"issue":"1","key":"796_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jhh.2008.81","volume":"23","author":"P Hiitola","year":"2009","unstructured":"Hiitola P, Enlund H, Kettunen R, Sulkava R, Hartikainen S. Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged 75 years or older. J Hum Hypertens. 2009;23(1):33\u20139.","journal-title":"J Hum Hypertens."},{"issue":"2","key":"796_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ageing\/2.2.112","volume":"2","author":"JR Cox","year":"1973","unstructured":"Cox JR, Admani AK, Agarwal ML, et al. Postural hypotension: body fluid compartments and electrolytes. Age Ageing. 1973;2(2):112\u201320.","journal-title":"Age Ageing"},{"issue":"5","key":"796_CR25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.HYP.8.5.438","volume":"8","author":"RP Shannon","year":"1986","unstructured":"Shannon RP, Wei JY, Rosa RM, Epstein FH, Rowe JW. The effect of age and sodium depletion on cardiovascular response to orthostasis. Hypertension. 1986;8(5):438\u201343.","journal-title":"Hypertension."},{"issue":"9","key":"796_CR26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1751-7176.2011.00512.x","volume":"13","author":"DA Sica","year":"2011","unstructured":"Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. J Clin Hypertens (Greenwich). 2011;13(9):639\u201343.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"11","key":"796_CR27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jamda.2018.06.021","volume":"19","author":"H Dills","year":"2018","unstructured":"Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q. Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc. 2018;19(11):923\u201335.","journal-title":"J Am Med Dir Assoc."},{"issue":"5","key":"796_CR28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/HJH.0b013e3283279860","volume":"27","author":"A Fedorowski","year":"2009","unstructured":"Fedorowski A, Burri P, Melander O. Orthostatic hypotension in genetically related hypertensive and normotensive individuals. J Hypertens. 2009;27(5):976\u201382.","journal-title":"J Hypertens."},{"issue":"5","key":"796_CR29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/jgs.12205","volume":"61","author":"AK Wong","year":"2013","unstructured":"Wong AK, Lord SR, Sturnieks DL, Delbaere K, Trollor JN, Close JC. Angiotensin system-blocking medications are associated with fewer falls over 12 months in community-dwelling older people. J Am Geriatr Soc. 2013;61(5):776\u201381.","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"796_CR30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/HJH.0000000000000781","volume":"34","author":"Y Press","year":"2016","unstructured":"Press Y, Punchik B, Freud T. Orthostatic hypotension and drug therapy in patients at an outpatient comprehensive geriatric assessment unit. J Hypertens. 2016;34(2):351\u20138.","journal-title":"J Hypertens."},{"issue":"6","key":"796_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12603-019-1201-2","volume":"23","author":"ZB Wojszel","year":"2019","unstructured":"Wojszel ZB, Kasiukiewicz A, Magnuszewski L. Health and functional determinants of orthostatic hypotension in geriatric ward patients: a retrospective cross sectional cohort study. J Nutr Health Aging. 2019;23(6):509\u201317.","journal-title":"J Nutr Health Aging."},{"issue":"3","key":"796_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1442-2042.2007.01956.x","volume":"15","author":"DA Schwinn","year":"2008","unstructured":"Schwinn DA, Roehrborn CG. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol. 2008;15(3):193\u20139.","journal-title":"Int J Urol."},{"key":"796_CR33","first-page":"209","volume":"126","author":"S Tatemichi","year":"2006","unstructured":"Tatemichi S, Kobayashi K, Maezawa A, Kobayashi M, Yamazaki Y, Shibata N. Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213). Yakugaku Zasshi. 2006;126:209\u201316.","journal-title":"Yakugaku Zasshi"},{"issue":"11","key":"796_CR34","first-page":"CD012615","volume":"11","author":"JH Jung","year":"2017","unstructured":"Jung JH, Kim J, MacDonald R, Reddy B, Kim MH, Dahm P. Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst Rev. 2017;11(11):CD012615.","journal-title":"Cochrane Database Syst Rev."},{"key":"796_CR35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eursup.2010.04.001","volume":"9","author":"F Montorsi","year":"2010","unstructured":"Montorsi F. Profile of silodosin. Eur Urol Suppl. 2010;9:491\u20135.","journal-title":"Eur Urol Suppl"},{"issue":"3","key":"796_CR36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","volume":"59","author":"CR Chapple","year":"2011","unstructured":"Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fern\u00e1ndez Fern\u00e1ndez E, European Silodosin Study Group. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol. 2011;59(3):342\u201352.","journal-title":"Eur Urol."},{"issue":"1","key":"796_CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40261-014-0257-3","volume":"35","author":"J Fonseca","year":"2015","unstructured":"Fonseca J, da Silva MC. The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with \u03b1-blockers: focus on silodosin. Clin Drug Investig. 2015;35(1):7\u201318.","journal-title":"Clin Drug Investig."},{"key":"796_CR38","doi-asserted-by":"crossref","first-page":"f6320","DOI":"10.1136\/bmj.f6320","volume":"347","author":"ST Bird","year":"2013","unstructured":"Bird ST, Delaney JA, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology. BMJ. 2013;347:f6320.","journal-title":"BMJ"},{"issue":"23","key":"796_CR39","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.100.23.2336","volume":"100","author":"XL Rudner","year":"1999","unstructured":"Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D\u2019Amico EB, El-Moalem H, Page SO, Richardson CD, Winters B, Marucci L, Schwinn DA. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation. 1999;100(23):2336\u201343.","journal-title":"Circulation."},{"issue":"5","key":"796_CR40","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","volume":"57","author":"K Hatzimouratidis","year":"2010","unstructured":"Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E, European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804\u201314.","journal-title":"Eur Urol."},{"issue":"5","key":"796_CR41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","volume":"61","author":"M Gacci","year":"2012","unstructured":"Gacci M, Corona G, Salvi M, Vignozzi L, McVary KT, Kaplan SA, Roehrborn CG, Serni S, Mirone V, Carini M, Maggi M. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2012;61(5):994\u20131003.","journal-title":"Eur Urol."},{"issue":"33","key":"796_CR42","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J."},{"issue":"3","key":"796_CR43","first-page":"160","volume":"55","author":"R Ylitalo","year":"2005","unstructured":"Ylitalo R, K\u00e4h\u00f6nen M, Nieminen T, K\u00f6\u00f6bi T, Ylitalo P, Turjanmaa V. Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers. Arzneimittelforschung. 2005;55(3):160\u20136.","journal-title":"Arzneimittelforschung."},{"key":"796_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4172\/2167-1095.1000104","volume":"1","author":"V Milazzo","year":"2012","unstructured":"Milazzo V, Stefano CD, Servo S, Crudo V, Fulcheri C, Maule S, et al. Drugs and orthostatic hypotension: evidence from literature. J Hypertens. 2012;1:104. https:\/\/doi.org\/10.4172\/2167-1095.1000104.","journal-title":"J Hypertens"},{"issue":"8","key":"796_CR45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/jgs.15421","volume":"66","author":"G Testa","year":"2018","unstructured":"Testa G, Ceccofiglio A, Mussi C, Bellelli G, Nicosia F, Bo M, Riccio D, Curcio F, Martone AM, Noro G, Landi F, Ungar A, Abete P. Hypotensive drugs and syncope due to orthostatic hypotension in older adults with dementia (syncope and dementia study). J Am Geriatr Soc. 2018;66(8):1532\u20137.","journal-title":"J Am Geriatr Soc."},{"issue":"1","key":"796_CR46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/HJH.0b013e32834d3d73","volume":"30","author":"F Valbusa","year":"2012","unstructured":"Valbusa F, Labat C, Salvi P, Vivian ME, Hanon O, Benetos A, PARTAGE investigators. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30(1):53\u201360.","journal-title":"J Hypertens."},{"issue":"4","key":"796_CR47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/HYPERTENSIONAHA.118.11337","volume":"72","author":"SP Juraschek","year":"2018","unstructured":"Juraschek SP, Appel LJ, Miller ER, Mukamal KJ, Lipsitz LA. Hypertension treatment effects on orthostatic hypotension and its relationship with cardiovascular disease. Hypertension. 2018;72(4):986\u201393.","journal-title":"Hypertension."},{"issue":"6957","key":"796_CR48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bmj.309.6957.775","volume":"309","author":"H Krum","year":"1994","unstructured":"Krum H, Conway EL, Broadbear JH, Howes LG, Louis WJ. Postural hypotension in elderly patients given carvedilol. BMJ. 1994;309(6957):775\u20136.","journal-title":"BMJ."},{"issue":"8","key":"796_CR49","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1001\/archinte.1991.00400080122024","volume":"151","author":"JR Oster","year":"1991","unstructured":"Oster JR, Epstein M. Use of centrally acting sympatholytic agents in the management of hypertension. Arch Intern Med. 1991;151(8):1638\u201344.","journal-title":"Arch Intern Med."},{"issue":"4","key":"796_CR50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/jhh.2013.82","volume":"31","author":"C Gaxatte","year":"2017","unstructured":"Gaxatte C, Faraj E, Lathuillerie O, Salleron J, Deramecourt V, Pardessus V, Destailleur MH, Boulanger E, Puisieux F. Alcohol and psychotropic drugs: risk factors for orthostatic hypotension in elderly fallers. J Hum Hypertens. 2017;31(4):299\u2013304.","journal-title":"J Hum Hypertens."},{"issue":"1","key":"796_CR51","first-page":"82","volume":"21","author":"AK Amery","year":"1972","unstructured":"Amery AK, Bossaert H, Fagard RH, et al. Clonidine versus methyldopa: a double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect. Acta Cardiol. 1972;21(1):82\u201399.","journal-title":"Acta Cardiol"},{"issue":"1","key":"796_CR52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-8703(89)90693-5","volume":"117","author":"F Forette","year":"1989","unstructured":"Forette F, McClaran J, Hervy MP, Bouchacourt P, Henry JF. Nicardipine in elderly patients with hypertension: a review of experience in France. Am Heart J. 1989;117(1):256\u201361.","journal-title":"Am Heart J"},{"issue":"10","key":"796_CR53","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/gps.2638","volume":"26","author":"SP Kennelly","year":"2011","unstructured":"Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA. Demonstration of safety in Alzheimer\u2019s patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study. Int J Geriatr Psychiatry. 2011;26(10):1038\u201345.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"13","key":"796_CR54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2318-13-73","volume":"15","author":"R Romero-Ortuno","year":"2013","unstructured":"Romero-Ortuno R, O\u2019Connell MD, Finucane C, Soraghan C, Fan CW, Kenny RA. Insights into the clinical management of the syndrome of supine hypertension\u2013orthostatic hypotension (SH-OH): the Irish Longitudinal Study on Ageing (TILDA). BMC Geriatr. 2013;15(13):73.","journal-title":"BMC Geriatr."},{"issue":"10","key":"796_CR55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/jhh.2014.130","volume":"29","author":"C Di Stefano","year":"2015","unstructured":"Di Stefano C, Milazzo V, Totaro S, Sobrero G, Ravera A, Milan A, Maule S, Veglio F. Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic. J Hum Hypertens. 2015;29(10):599\u2013603.","journal-title":"J Hum Hypertens."},{"issue":"Suppl 5","key":"796_CR56","first-page":"S2","volume":"67","author":"LH Opie","year":"1991","unstructured":"Opie LH. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine. Postgrad Med J. 1991;67(Suppl 5):S2\u20138.","journal-title":"Postgrad Med J."},{"key":"796_CR57","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00004872-199310000-00016","volume":"11","author":"BM Egan","year":"1993","unstructured":"Egan BM, Fleissner MJ, Stepniakowski K, Neahring JM, Sagar KB, Ebert TJ. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J. Hypertens. 1993;11:1113\u201320.","journal-title":"J. Hypertens"},{"issue":"1","key":"796_CR58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3317\/jraas.2000.009","volume":"1","author":"JB Park","year":"2000","unstructured":"Park JB, Intengan HD, Schiffrin EL. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension. J Renin Angiotensin Aldosterone Syst. 2000;1(1):40\u20135.","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"issue":"12","key":"796_CR59","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0895-7061(02)02982-5","volume":"15","author":"A Mahmud","year":"2002","unstructured":"Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens. 2002;15(12):1092\u20135.","journal-title":"Am J Hypertens."},{"issue":"2","key":"796_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2125.1991.tb05522.x","volume":"31","author":"S Capewell","year":"1991","unstructured":"Capewell S, Capewell A. \u2018First dose\u2019 hypotension and venodilatation. Br J Clin Pharmacol. 1991;31(2):213\u20135.","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"796_CR61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.jhh.1000788","volume":"13","author":"JL Pool","year":"1999","unstructured":"Pool JL, Glazer R, Chiang YT, Gatlin M. Dose-response efficacy of valsartan, a new angiotensin II receptor blocker. J Hum Hypertens. 1999;13(4):275\u201381.","journal-title":"J Hum Hypertens."},{"issue":"6 Pt 1","key":"796_CR62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0895-7061(00)01304-2","volume":"14","author":"MR Weir","year":"2001","unstructured":"Weir MR, Weber MA, Neutel JM, Vendetti J, Michelson EL, Wang RY. Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators. Am J Hypertens. 2001;14(6 Pt 1):567\u201372.","journal-title":"Am J Hypertens."},{"issue":"6","key":"796_CR63","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00005344-199906000-00017","volume":"33","author":"R Ha\u00efat","year":"1999","unstructured":"Ha\u00efat R, Piot O, Gallois H, Hanania G. Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists. J Cardiovasc Pharmacol. 1999;33(6):953\u20139.","journal-title":"J Cardiovasc Pharmacol."},{"issue":"4","key":"796_CR64","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1185\/0300799019117016","volume":"17","author":"L Anthopoulos","year":"2001","unstructured":"Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure. Curr Med Res Opin. 2001;17(4):290\u20137.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"796_CR65","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002512-200926050-00002","volume":"26","author":"A Darowski","year":"2009","unstructured":"Darowski A, Chambers SA, Chambers DJ. Antidepressants and falls in the elderly. Drugs Aging. 2009;26(5):381\u201394.","journal-title":"Drugs Aging."},{"issue":"4","key":"796_CR66","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3724\/SP.J.1263.2011.00243","volume":"8","author":"G Marano","year":"2011","unstructured":"Marano G, Traversi G, Romagnoli E, et al. Cardiologic side effects of psychotropic drugs. J Geriatr Cardiol. 2011;8(4):243\u201353. https:\/\/doi.org\/10.3724\/SP.J.1263.2011.00243.","journal-title":"J Geriatr Cardiol."},{"issue":"8","key":"796_CR67","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jash.2018.06.002","volume":"12","author":"R Briggs","year":"2018","unstructured":"Briggs R, Carey D, McNicholas T, Claffey P, Nolan H, Kennelly SP, Kenny RA. The association between antidepressant use and orthostatic hypotension in older people: a matched cohort study. J Am Soc Hypertens. 2018;12(8):597\u2013604.e1.","journal-title":"J Am Soc Hypertens."},{"issue":"5","key":"796_CR68","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.117.10542","volume":"71","author":"R Briggs","year":"2018","unstructured":"Briggs R, Carey D, Kennelly SP, Kenny RA. Longitudinal association between orthostatic hypotension at 30 seconds post-standing and late-life depression. Hypertension. 2018;71(5):946\u201354.","journal-title":"Hypertension."},{"issue":"3","key":"796_CR69","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.bjp.0702571","volume":"127","author":"P Pacher","year":"1999","unstructured":"Pacher P, Ungvari Z, Kecskemeti V, Koller A. Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity. Br J Pharmacol. 1999;127(3):740\u20136.","journal-title":"Br J Pharmacol."},{"issue":"9","key":"796_CR70","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.STR.30.9.1949","volume":"30","author":"Z Ungvari","year":"1999","unstructured":"Ungvari Z, Pacher P, Kecskem\u00e9ti V, Koller A. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke. 1999;30(9):1949\u201354.","journal-title":"Stroke."},{"issue":"6","key":"796_CR71","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/0929867306666220330184544","volume":"6","author":"P Pacher","year":"1999","unstructured":"Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem. 1999;6(6):469\u201380.","journal-title":"Curr Med Chem."},{"key":"796_CR72","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0024-3205(79)90466-1","volume":"25","author":"RW Fuller","year":"1979","unstructured":"Fuller RW, Holland DR, Yen TT, Bemis KG, Stamm NB. Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats. Life Sci. 1979;25:1237\u201342.","journal-title":"Life Sci"},{"issue":"6","key":"796_CR73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gr\u00fcnder G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, M\u00fcller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44(6):195\u2013235.","journal-title":"Pharmacopsychiatry."},{"issue":"9","key":"796_CR74","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.JGP.0000204328.50105.b3","volume":"14","author":"EM Johnson","year":"2006","unstructured":"Johnson EM, et al. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry. 2006;14(9):796\u2013802.","journal-title":"Am J Geriatr Psychiatry."},{"issue":"1","key":"796_CR75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/jcp.0b013e318160738e","volume":"28","author":"J Raskin","year":"2008","unstructured":"Raskin J, Wiltse CG, Dinkel JJ, Walker DJ, Desaiah D, Katona C. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder. J Clin Psychopharmacol. 2008;28(1):32\u20138.","journal-title":"J Clin Psychopharmacol."},{"key":"796_CR76","doi-asserted-by":"crossref","unstructured":"Alexandrino-Silva C, Nadalini Mau\u00e1 FH, de Andrade AG, de Toledo Ferraz Alves TC. Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms. J Psychopharmacol. 2008;22(2):214\u20136.","DOI":"10.1177\/0269881107076403"},{"key":"796_CR77","volume-title":"Goodman and Gilman\u2019s manual of pharmacology and therapeutics","author":"LL Brunton","year":"2011","unstructured":"Brunton LL, Parker KL, Blumenthal DK, Buxton ILO. Goodman and Gilman\u2019s manual of pharmacology and therapeutics. 12th ed. New York: The Mac Graw Hill Company; 2011.","edition":"12"},{"issue":"4","key":"796_CR78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002512-199404040-00006","volume":"4","author":"M Haria","year":"1994","unstructured":"Haria M, Fitton A, McTavish D. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging. 1994;4(4):331\u201355.","journal-title":"Drugs Aging."},{"issue":"12","key":"796_CR79","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","volume":"26","author":"A Fagiolini","year":"2012","unstructured":"Fagiolini A, Comandini A, Catena Dell\u2019Osso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26(12):1033\u201349.","journal-title":"CNS Drugs."},{"issue":"3","key":"796_CR80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0016-5107(89)72764-4","volume":"35","author":"RH Hartke Jr","year":"1989","unstructured":"Hartke RH Jr, Gonzalez-Rothi RJ, Abbey NC. Midazolam-associated alterations in cardiorespiratory function during colonoscopy. Gastrointest Endosc. 1989;35(3):232\u20138.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"796_CR81","first-page":"113","volume":"65","author":"J Marty","year":"1986","unstructured":"Marty J, Gauzit R, Lefevre P, Couderc E, Farinotti R, Henzel C, Desmonts JM. Effects of diazepam and midazolam on baroreflex control of heart rate and on sympathetic activity in humans. Anesth Analg. 1986;65(2):113\u20139.","journal-title":"Anesth Analg"},{"issue":"12a","key":"796_CR82","first-page":"2268","volume":"31","author":"PN Samuelson","year":"1981","unstructured":"Samuelson PN, Reves JG, Smith LR, Kouchoukos NT. Midazolam versus diazepam: different effects on systemic vascular resistance. A randomized study utilizing cardiopulmonary bypass constant flow. Arzneimittelforschung. 1981;31(12a):2268\u20139.","journal-title":"Arzneimittelforschung"},{"key":"796_CR83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2019.10.032","volume":"72","author":"G Rivasi","year":"2020","unstructured":"Rivasi G, Kenny RA, Ungar A, Romero-Ortuno R. Effects of benzodiazepines on orthostatic blood pressure in older people. Eur J Intern Med. 2020;72:73\u20138.","journal-title":"Eur J Intern Med."},{"issue":"1","key":"796_CR84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005344-200301000-00005","volume":"41","author":"SJ Shi","year":"2003","unstructured":"Shi SJ, Garcia KM, Meck JV. Temazepam, but not zolpidem, causes orthostatic hypotension in astronauts after spaceflight. J Cardiovasc Pharmacol. 2003;41(1):31\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"16","key":"796_CR85","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0024-3205(98)00411-1","volume":"63","author":"A Zeegers","year":"1998","unstructured":"Zeegers A, van Wilgenburg H, Leeuwin RS. Cardiac effects of benzodiazepine receptor agonists and antagonists in the isolated rat heart: a comparative study. Life Sci. 1998;63(16):1439\u201356.","journal-title":"Life Sci"},{"issue":"1","key":"796_CR86","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1378\/chest.106.1.194","volume":"106","author":"J Harding","year":"1994","unstructured":"Harding J, Kemper M, Weissman C. Midazolam attenuates the metabolic and cardiopulmonary responses to an acute increase in oxygen demand. Chest. 1994;106(1):194\u2013200.","journal-title":"Chest"},{"issue":"2","key":"796_CR87","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00003246-200002000-00005","volume":"28","author":"Y Kamijo","year":"2000","unstructured":"Kamijo Y, Masuda T, Nishikawa T, Tsuruta H, Ohwada T. Cardiovascular response and stress reaction to flumazenil injection in patients under infusion with midazolam. Crit Care Med. 2000;28(2):318\u201323.","journal-title":"Crit Care Med"},{"issue":"4","key":"796_CR88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000289072","volume":"65","author":"F Lechin","year":"1996","unstructured":"Lechin F, van der Dijs B, Benaim M. Benzodiazepines: tolerability in elderly patients. Psychother Psychosom. 1996;65(4):171\u201382.","journal-title":"Psychother Psychosom"},{"issue":"Suppl 1","key":"796_CR89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hup.915","volume":"23","author":"P Mackin","year":"2008","unstructured":"Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol. 2008;23(Suppl 1):3\u201314.","journal-title":"Hum Psychopharmacol."},{"issue":"2","key":"796_CR90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","volume":"135","author":"JY Leung","year":"2012","unstructured":"Leung JY, Barr AM, Procyshyn RM, Honer WG, Pang CC. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. Pharmacol Ther. 2012;135(2):113\u201322.","journal-title":"Pharmacol Ther."},{"issue":"8","key":"796_CR91","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/11591710-000000000-00000","volume":"25","author":"JJ Gugger","year":"2011","unstructured":"Gugger JJ. Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management. CNS Drugs. 2011;25(8):659\u201371.","journal-title":"CNS Drugs."},{"key":"796_CR92","first-page":"459","volume":"51","author":"H Silver","year":"1990","unstructured":"Silver H, Kogan H, Zlotogorski D. Postural hypotension in chronically medicated schizophrenics. J Clin Psychiatry. 1990;51:459\u201362.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"796_CR93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/11318330-000000000-00000","volume":"27","author":"LD Wood","year":"2010","unstructured":"Wood LD. Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson\u2019s disease. Drugs Aging. 2010;27(4):295\u2013310.","journal-title":"Drugs Aging."},{"issue":"2","key":"796_CR94","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.63.2.228","volume":"63","author":"A Churchyard","year":"1997","unstructured":"Churchyard A, Mathias CJ, Boonkongchuen P, Lees AJ. Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;63(2):228\u201334.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"796_CR95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1531-8257(199903)14:2<246::AID-MDS1008>3.0.CO;2-P","volume":"14","author":"A Churchyard","year":"1999","unstructured":"Churchyard A, Mathias CJ, Lees AJ. Selegiline-induced postural hypotension in Parkinson\u2019s disease: a longitudinal study on the effects of drug withdrawal. Mov Disord. 1999;14(2):246\u201351.","journal-title":"Mov Disord."},{"issue":"3","key":"796_CR96","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bjp.0705962","volume":"143","author":"ZA Abassi","year":"2004","unstructured":"Abassi ZA, Binah O, Youdim MB. Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline. Br J Pharmacol. 2004;143(3):371\u20138.","journal-title":"Br J Pharmacol."},{"issue":"5","key":"796_CR97","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2012.01.012","volume":"18","author":"S Perez-Lloret","year":"2012","unstructured":"Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Senard JM, Pavy-Le Traon A, Montastruc JL, Rascol O. Factors related to orthostatic hypotension in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18(5):501\u20135.","journal-title":"Parkinsonism Relat Disord."},{"issue":"1","key":"796_CR98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jamda.2019.01.124","volume":"21","author":"F Curcio","year":"2020","unstructured":"Curcio F, Testa G, Ceccofiglio A, Martone AM, Riccio D, Nicosia F, Noro G, Bellelli G, Bo M, Mussi C, Landi F, Ungar A, Abete P. Memantine induces reflex syncope in elderly patients with dementia: results from the syncope and dementia study (SYD-Study). J Am Med Dir Assoc. 2020;21(1):130\u20132.","journal-title":"J Am Med Dir Assoc."},{"key":"796_CR99","doi-asserted-by":"crossref","first-page":"e003423","DOI":"10.1161\/CIRCHEARTFAILURE.116.003423","volume":"9","author":"NM Sharma","year":"2016","unstructured":"Sharma NM, Cunningham CJ, Zheng H, et al. Hypoxia-inducible Factor-1a mediates increased sympathoexcitation via glutamatergic N-Methyld-Aspartate receptors in the paraventricular nucleus of rats with chronic heart failure. Circ Heart Fail. 2016;9:e003423.","journal-title":"Circ Heart Fail."},{"key":"796_CR100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pds.1620","volume":"17","author":"A Gallini","year":"2008","unstructured":"Gallini A, Sommet A, Montastrue JL. French PharmacoVigilance network: does memantine induce bradycardia? Pharmacoepidemiol Drug Saf. 2008;17:877\u201381.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"796_CR101","first-page":"387","volume":"6","author":"CF Huang","year":"1999","unstructured":"Huang CF, Su MJ. Positive ionotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. J Biomed Sci. 1999;6:387\u201398.","journal-title":"J Biomed Sci."},{"issue":"12","key":"796_CR102","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00702-017-1791-y","volume":"124","author":"S Eschlb\u00f6ck","year":"2017","unstructured":"Eschlb\u00f6ck S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna). 2017;124(12):1567\u2013605.","journal-title":"J Neural Transm (Vienna)."},{"issue":"8","key":"796_CR103","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567\u201382.","journal-title":"J Neurol."},{"key":"796_CR104","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jch.13521","volume":"21","author":"N Magkas","year":"2019","unstructured":"Magkas N, Tsioufis C, Thomopoulos C, Dilaveris P, Georgiopoulos G, Sanidas E, et al. Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens. 2019;21:546\u201354.","journal-title":"J Clin Hypertens."},{"issue":"8","key":"796_CR105","first-page":"e3166","volume":"10","author":"A Ali","year":"2018","unstructured":"Ali A, Ali NS, Waqas N, Bhan C, Iftikhar W, Sapna F, et al. Management of orthostatic hypotension: a literature review. Cureus. 2018;10(8):e3166.","journal-title":"Cureus."},{"issue":"12","key":"796_CR106","first-page":"2145","volume":"26","author":"H Pittner","year":"1976","unstructured":"Pittner H, Stormann H, Enzenhofer R. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059. Arzneimittelforschung. 1976;26(12):2145\u201354.","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"796_CR107","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","volume":"51","author":"RA Wright","year":"1998","unstructured":"Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51(1):120\u20134.","journal-title":"Neurology."},{"issue":"13","key":"796_CR108","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"277","author":"PA Low","year":"1997","unstructured":"Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997;277(13):1046\u201351.","journal-title":"JAMA."},{"issue":"1","key":"796_CR109","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","volume":"95","author":"J Jankovic","year":"1993","unstructured":"Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95(1):38\u201348.","journal-title":"Am J Med."},{"issue":"6","key":"796_CR110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0002-9343(99)80246-0","volume":"99","author":"FM Fouad-Tarazi","year":"1995","unstructured":"Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med. 1995;99(6):604\u201310.","journal-title":"Am J Med."},{"issue":"4","key":"796_CR111","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"A Fanciulli","year":"2018","unstructured":"Fanciulli A, Jordan J, Biaggioni I, Calandra-Buonaura G, Cheshire WP, Cortelli P, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018;28(4):355\u201362. https:\/\/doi.org\/10.1007\/s10286-018-0529-8.","journal-title":"Clin Auton Res."},{"issue":"7","key":"796_CR112","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jacc.2015.06.1084","volume":"66","author":"F Ricci","year":"2015","unstructured":"Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66(7):848\u201360.","journal-title":"J Am Coll Cardiol."},{"issue":"9","key":"796_CR113","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","volume":"53","author":"R Freeman","year":"1999","unstructured":"Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology. 1999;53(9):2151\u20137.","journal-title":"Neurology."},{"issue":"6","key":"796_CR114","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","volume":"108","author":"H Kaufmann","year":"2003","unstructured":"Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation. 2003;108(6):724\u20138.","journal-title":"Circulation."},{"issue":"4","key":"796_CR115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328\u201335.","journal-title":"Neurology."},{"issue":"5","key":"796_CR116","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B). Mov Disord. 2015;30(5):646\u201354.","journal-title":"Mov Disord."},{"issue":"1","key":"796_CR117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","volume":"65","author":"I Biaggioni","year":"2015","unstructured":"Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65(1):101\u20137.","journal-title":"Hypertension."},{"issue":"1","key":"796_CR118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","volume":"4","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson\u2019s disease (NOH306A). J Parkinsons Dis. 2014;4(1):57\u201365.","journal-title":"J Parkinsons Dis."},{"issue":"4","key":"796_CR119","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02298955","volume":"11","author":"CJ Mathias","year":"2001","unstructured":"Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res. 2001;11(4):235\u201342.","journal-title":"Clin Auton Res."},{"issue":"8569","key":"796_CR120","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(87)91317-1","volume":"2","author":"I Biaggioni","year":"1987","unstructured":"Biaggioni I, Robertson D. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet (Lond, Engl). 1987;2(8569):1170\u20132.","journal-title":"Lancet (Lond, Engl)."},{"issue":"7","key":"796_CR121","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.38.7.1091","volume":"38","author":"T Kachi","year":"1988","unstructured":"Kachi T, Iwase S, Mano T, Sakoda S, Hayashi A, Yamamura Y, et al. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Neurology. 1988;38(7):1091\u20134.","journal-title":"Neurology."},{"issue":"2","key":"796_CR122","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02260889","volume":"3","author":"H Kaufmann","year":"1991","unstructured":"Kaufmann H, Oribe E, Yahr MD. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure. J Neural Transm Park Dis Dement Sect. 1991;3(2):143\u20138.","journal-title":"J Neural Transm Park Dis Dement Sect."},{"issue":"2","key":"796_CR123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40265-014-0342-1","volume":"75","author":"GM Keating","year":"2015","unstructured":"Keating GM. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension. Drugs. 2015;75(2):197\u2013206.","journal-title":"Drugs."},{"issue":"5","key":"796_CR124","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1060028016689264","volume":"51","author":"GM Hale","year":"2017","unstructured":"Hale GM, Valdes J, Brenner M. The treatment of primary orthostatic hypotension. Ann Pharmacother. 2017;51(5):417\u201328.","journal-title":"Ann Pharmacother."},{"issue":"2","key":"796_CR125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM197907123010202","volume":"301","author":"AV Chobanian","year":"1979","unstructured":"Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;301(2):68\u201373.","journal-title":"N Engl J Med."},{"issue":"4","key":"796_CR126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diab.24.4.381","volume":"24","author":"IW Campbell","year":"1975","unstructured":"Campbell IW, Ewing DJ, Clarke BF. 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes. 1975;24(4):381\u20134.","journal-title":"Diabetes."},{"issue":"7","key":"796_CR127","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ijcp.12122","volume":"67","author":"AC Ong","year":"2013","unstructured":"Ong AC, Myint PK, Shepstone L, Potter JF. A systematic review of the pharmacological management of orthostatic hypotension. Int J Clin Pract. 2013;67(7):633\u201346.","journal-title":"Int J Clin Pract."},{"issue":"7","key":"796_CR128","first-page":"367","volume":"36","author":"T Hakam\u00e4ki","year":"1998","unstructured":"Hakam\u00e4ki T, Rajala T, Lehtonen A. Ambulatory 24-hour blood pressure recordings in patients with Parkinson\u2019s disease with or without fludrocortisone. Int J Clin Pharmacol Ther. 1998;36(7):367\u20139.","journal-title":"Int J Clin Pharmacol Ther."},{"issue":"2","key":"796_CR129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2796.1992.tb00563.x","volume":"232","author":"AD Ten Harkel","year":"1992","unstructured":"Ten Harkel AD, Van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232(2):139\u201345.","journal-title":"J Intern Med."},{"key":"796_CR130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02291388","volume":"10","author":"JJ van Lieshout","year":"2000","unstructured":"van Lieshout JJ, ten Harkel ADJ, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35\u201342.","journal-title":"Clin Auton Res"},{"issue":"9","key":"796_CR131","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.74.9.1294","volume":"74","author":"W Singer","year":"2003","unstructured":"Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74(9):1294\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"796_CR132","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","volume":"63","author":"W Singer","year":"2006","unstructured":"Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513\u20138.","journal-title":"Arch Neurol."},{"issue":"5","key":"796_CR133","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.wnp.0000229946.01494.4c","volume":"23","author":"W Singer","year":"2006","unstructured":"Singer W, Opfer-Gehrking TL, Nickander KK, Hines SM, Low PA. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin Neurophysiol. 2006;23(5):476\u201381.","journal-title":"J Clin Neurophysiol."},{"issue":"12 Pt 2","key":"796_CR134","first-page":"1664","volume":"13","author":"M Alam","year":"1995","unstructured":"Alam M, Smith G, Bleasdale-Barr K, Pavitt DV, Mathias CJ. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens. 1995;13(12 Pt 2):1664\u20139.","journal-title":"J Hypertens."},{"issue":"6543","key":"796_CR135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.293.6543.353","volume":"293","author":"CJ Mathias","year":"1986","unstructured":"Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed). 1986;293(6543):353\u20134.","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"9","key":"796_CR136","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM199308263290904","volume":"329","author":"RD Hoeldtke","year":"1993","unstructured":"Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993;329(9):611\u20135.","journal-title":"N Engl J Med."},{"issue":"3","key":"796_CR137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10286-002-0031-0","volume":"12","author":"SV Rao","year":"2002","unstructured":"Rao SV, Stamler JS. Erythropoietin, anemia, and orthostatic hypotension: the evidence mounts. Clin Auton Res. 2002;12(3):141\u20133.","journal-title":"Clin Auton Res."}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00796-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:16:25Z","timestamp":1668647785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00796-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":137,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00796-5","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"7 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript. Open access funding provided by Universit\u00e0 degli Studi di Firenze within the CRUI-CARE Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Giulia Rivasi, Martina Rafanelli, Enrico Mossello, Michele Brignole, and Andrea Ungar declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Study conception and design: Rivasi; literature search, draft and\/or critical revision of the work and approval of final manuscript: all authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}